251 related articles for article (PubMed ID: 32359398)
21. HdmX overexpression inhibits oncogene induced cellular senescence.
Miller KR; Kelley K; Tuttle R; Berberich SJ
Cell Cycle; 2010 Aug; 9(16):3376-82. PubMed ID: 20724842
[TBL] [Abstract][Full Text] [Related]
22. Allosteric Interactions by p53 mRNA Govern HDM2 E3 Ubiquitin Ligase Specificity under Different Conditions.
Medina-Medina I; García-Beltrán P; de la Mora-de la Mora I; Oria-Hernández J; Millot G; Fahraeus R; Reyes-Vivas H; Sampedro JG; Olivares-Illana V
Mol Cell Biol; 2016 Aug; 36(16):2195-205. PubMed ID: 27215386
[TBL] [Abstract][Full Text] [Related]
23. Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization.
Giglio S; Mancini F; Gentiletti F; Sparaco G; Felicioni L; Barassi F; Martella C; Prodosmo A; Iacovelli S; Buttitta F; Farsetti A; Soddu S; Marchetti A; Sacchi A; Pontecorvi A; Moretti F
Cancer Res; 2005 Nov; 65(21):9687-94. PubMed ID: 16266988
[TBL] [Abstract][Full Text] [Related]
24. Hdmx modulates the outcome of p53 activation in human tumor cells.
Wade M; Wong ET; Tang M; Stommel JM; Wahl GM
J Biol Chem; 2006 Nov; 281(44):33036-44. PubMed ID: 16905769
[TBL] [Abstract][Full Text] [Related]
25. Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX.
Pazgier M; Liu M; Zou G; Yuan W; Li C; Li C; Li J; Monbo J; Zella D; Tarasov SG; Lu W
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4665-70. PubMed ID: 19255450
[TBL] [Abstract][Full Text] [Related]
26. Further insight into substrate recognition by USP7: structural and biochemical analysis of the HdmX and Hdm2 interactions with USP7.
Sarkari F; La Delfa A; Arrowsmith CH; Frappier L; Sheng Y; Saridakis V
J Mol Biol; 2010 Oct; 402(5):825-37. PubMed ID: 20713061
[TBL] [Abstract][Full Text] [Related]
27. Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.
Lemos A; Leão M; Soares J; Palmeira A; Pinto M; Saraiva L; Sousa ME
Med Res Rev; 2016 Sep; 36(5):789-844. PubMed ID: 27302609
[TBL] [Abstract][Full Text] [Related]
28. Cryptic in vitro ubiquitin ligase activity of HDMX towards p53 is probably regulated by an induced fit mechanism.
Calderon-González KG; Medina-Medina I; Haronikova L; Hernychova L; Bonczek O; Uhrik L; Hrabal V; Vojtesek B; Fahraeus R; Hernández-Monge J; Olivares-Illana V
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35674210
[TBL] [Abstract][Full Text] [Related]
29. Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2.
de Graaf P; Little NA; Ramos YF; Meulmeester E; Letteboer SJ; Jochemsen AG
J Biol Chem; 2003 Oct; 278(40):38315-24. PubMed ID: 12874296
[TBL] [Abstract][Full Text] [Related]
30. Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99.
Lee XA; Verma C; Sim AYL
Proteins; 2017 Aug; 85(8):1493-1506. PubMed ID: 28425639
[TBL] [Abstract][Full Text] [Related]
31. Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation.
Migliorini D; Danovi D; Colombo E; Carbone R; Pelicci PG; Marine JC
J Biol Chem; 2002 Mar; 277(9):7318-23. PubMed ID: 11744695
[TBL] [Abstract][Full Text] [Related]
32. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.
Meulmeester E; Maurice MM; Boutell C; Teunisse AF; Ovaa H; Abraham TE; Dirks RW; Jochemsen AG
Mol Cell; 2005 May; 18(5):565-76. PubMed ID: 15916963
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.
Pereg Y; Shkedy D; de Graaf P; Meulmeester E; Edelson-Averbukh M; Salek M; Biton S; Teunisse AF; Lehmann WD; Jochemsen AG; Shiloh Y
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5056-61. PubMed ID: 15788536
[TBL] [Abstract][Full Text] [Related]
34. RNAi knockdown of HdmX or Hdm2 leads to new insights into p53 signaling.
Berberich SJ
Cell Cycle; 2010 Sep; 9(18):3640-1. PubMed ID: 20855947
[No Abstract] [Full Text] [Related]
35. Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions.
Li C; Pazgier M; Li C; Yuan W; Liu M; Wei G; Lu WY; Lu W
J Mol Biol; 2010 Apr; 398(2):200-13. PubMed ID: 20226197
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation.
Wang YV; Wade M; Wong E; Li YC; Rodewald LW; Wahl GM
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12365-70. PubMed ID: 17640893
[TBL] [Abstract][Full Text] [Related]
37. Hdmx stabilizes Mdm2 and p53.
Stad R; Ramos YF; Little N; Grivell S; Attema J; van Der Eb AJ; Jochemsen AG
J Biol Chem; 2000 Sep; 275(36):28039-44. PubMed ID: 10827196
[TBL] [Abstract][Full Text] [Related]
38. Effect of linker on the binding free energy of stapled p53/HDM2 complex.
Im H; Ham S
PLoS One; 2020; 15(4):e0232613. PubMed ID: 32353067
[TBL] [Abstract][Full Text] [Related]
39. Structure-based design of high affinity peptides inhibiting the interaction of p53 with MDM2 and MDMX.
Phan J; Li Z; Kasprzak A; Li B; Sebti S; Guida W; Schönbrunn E; Chen J
J Biol Chem; 2010 Jan; 285(3):2174-83. PubMed ID: 19910468
[TBL] [Abstract][Full Text] [Related]
40. Avoiding drug resistance through extended drug target interfaces: a case for stapled peptides.
Wei SJ; Chee S; Yurlova L; Lane D; Verma C; Brown C; Ghadessy F
Oncotarget; 2016 May; 7(22):32232-46. PubMed ID: 27057630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
